N.M. Stat. Ann. § 26-1-2 – New Mexico

Status: Enacted
Link: http://public.nmcompcomm.us/nmpublic/gateway.dll/?f=templates&fn=default.htm

Amends the New Mexico Drug, Device and Cosmetic Act to allow pharmacists to substitute biosimilar and interchangeable biosimilar biologic products for another biologic product that has been prescribed by a physician.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment